Jasper Therapeutics- Warrants (24/09/2026) Profit Margin

As of the most recent data (March 2026), JSPRW shows a profit margin of -Infinity%. That compares with 27.57% in the prior-year period — down Infinity% year over year. That is below the sector sector average of 19.69%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JSPRW's profit margin is now -Infinity% (was 27.57%) — a Infinity% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Jasper Therapeutics- Warrants (24/09/2026) is outperforming or lagging.

The its sector sector average profit margin is about 19.69%. Jasper Therapeutics- Warrants (24/09/2026) is at -Infinity%, which is lower that average. That is roughly Infinity% below the sector mean. Use the comparison chart on this page to see how JSPRW stacks up against individual peers as well.

That compares with 27.57% in the prior-year period — down Infinity% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Jasper Therapeutics- Warrants (24/09/2026) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Jasper Therapeutics- Warrants (24/09/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -Infinity%) with ownership activity and broader fundamentals.